Advanced Financial Statements From 2010 to 2025
| ABMT Stock | USD 0.0004 0.0002 100.00% |
Check Advanced Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Advanced Biomedical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Advanced financial statements analysis is a perfect complement when working with Advanced Biomedical Valuation or Volatility modules.
Advanced |
Advanced Biomedical Technologies Company Shares Owned By Insiders Analysis
Advanced Biomedical's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Advanced Biomedical Shares Owned By Insiders | 3.32 % |
Most of Advanced Biomedical's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Advanced Biomedical Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 3.32% of Advanced Biomedical Technologies are shares owned by insiders. This is 78.13% lower than that of the Health Care Equipment & Supplies sector and 78.65% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 67.1% higher than that of the company.
Advanced Biomedical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Advanced Biomedical's current stock value. Our valuation model uses many indicators to compare Advanced Biomedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Advanced Biomedical competition to find correlations between indicators driving Advanced Biomedical's intrinsic value. More Info.Advanced Biomedical Technologies is number one stock in return on asset category among its peers. It is rated third in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Advanced Biomedical's earnings, one of the primary drivers of an investment's value.About Advanced Biomedical Financial Statements
Advanced Biomedical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Advanced Biomedical investors may analyze each financial statement separately, they are all interrelated. The changes in Advanced Biomedical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Advanced Biomedical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York. Advanced Biomedical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 17 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Advanced Pink Sheet Analysis
When running Advanced Biomedical's price analysis, check to measure Advanced Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Biomedical is operating at the current time. Most of Advanced Biomedical's value examination focuses on studying past and present price action to predict the probability of Advanced Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Biomedical's price. Additionally, you may evaluate how the addition of Advanced Biomedical to your portfolios can decrease your overall portfolio volatility.